SEMAX is a synthetic peptide derivative of adrenocorticotropic hormone (ACTH 4–10) studied for its potential neuroprotective and cognitive-enhancing properties. It has been widely researched for its influence on brain function, focus, and recovery following neurological injury, making it a notable compound in neuropharmacology and cognitive research.

Mechanism of Action:

SEMAX modulates the expression of brain-derived neurotrophic factor (BDNF) and other neurotrophins involved in synaptic plasticity, learning, and memory. It also interacts with dopaminergic and serotonergic systems, supporting neurotransmitter balance and neuroprotection. Preclinical evidence suggests it may help reduce oxidative stress, inflammation, and ischemic damage in neural tissue.

Research Highlights:

• Shown to enhance memory, learning capacity, and neuroplasticity in preclinical studies.
• Demonstrated neuroprotective effects in models of hypoxia, stroke, and neuroinflammation.
• Studied for its potential to modulate stress response and improve cognitive resilience.
• Non-toxic and stable under research conditions, making it suitable for ongoing neurocognitive research

Disclaimer:
For research use only. Not for human consumption. Intended for qualified laboratory professionals conducting controlled scientific studies.